Aptevo Therapeutics Announces Closing of $2.75 Million Offering

July 1, 2024 4:20 PM

SEATTLE, WA / ACCESSWIRE / July 1, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced the closing of its previously announced offering of (i) 5,339,806 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate...

Read more

Gloria Gates CARE Opens New Enhanced Primary CARE Center in Berwick, PA

July 1, 2024 1:30 PM

Gloria Gates CARE, a new standard of healthcare for Medicaid and Medicare beneficiaries or those without insurance, is proud to announce the opening of its second Enhanced Primary CARE Center in Berwick, Pennsylvania in June. This location was specifically selected following the closure of the borough's only hospital in 2022. Two long-time area practitioners, Dallas Riley and Michelle Hall, will join Gloria Gates Care as part of the new...

Read more

The Assistance Fund Adds Three New Members to Board of Directors

July 1, 2024 12:00 PM

Linda Howard, Daniel Klein, and John Rushing Join The Assistance Fund's Board of DirectorsORLANDO, FL / ACCESSWIRE / July 1, 2024 / The Assistance Fund (TAF), an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the addition of three new members to its Board of Directors. Linda Howard, Daniel Klein, and John Rushing join TAF's all-volunteer Board,...

Read more

Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains

July 1, 2024 11:20 AM

CHICAGO, IL / ACCESSWIRE / July 1, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has signed a distribution agreement (the "Agreement") with ZENDON...

Read more

VerticalVet and Movora Partner to Enhance Veterinary Surgery, Orthopedics and Continuing Education

July 1, 2024 10:00 AM

Reflecting a shared commitment to the ongoing education and professional development of veterinary teamsSAINT AUGUSTINE, FL / ACCESSWIRE / July 1, 2024 / VerticalVet, the leading network focused on enhancing veterinary practices, is thrilled to announce a new strategic partnership with Movora, a premier provider of veterinary surgical and orthopedic solutions. This collaboration is set to begin on July 1, 2024, and promises to bring a vast array...

Read more

Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment

July 1, 2024 9:30 AM

Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Company is entering into a worldwide exclusive licensing agreement for US Patent # 8067531-B2, "Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells," applying Immunotherapy Treatment to the global fight against cancer. ENZC continues to explore therapeutic applications of the patent, and is preparing to...

Read more

Gilead Benefit Helps Employees Navigate Cancer Care

July 1, 2024 8:45 AM

NORTHAMPTON, MA / ACCESSWIRE / July 1, 2024 / Jim Candler had a successful 40-year career in system operations before coming to Gilead three years ago to bring his tech expertise to the Human Resources team."I was hired at 71 years old. What does that say about Gilead?" says Jim, Senior Director, People Technology.Jim is now 74 years old and still enjoys coming to work every day. He feels especially fortunate to be working at a company that...

Read more

US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians

July 1, 2024 6:30 AM

Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, is honored to announce that the United States Equestrian Federation (USEF), which regularly competes in FEI Team Competitions, Olympics and Paralympics, has named PulseVet as the Official Shock Wave Therapy Supplier of US Equestrian team veterinarians."US...

Read more

NanoViricides is Well Positioned with Its Clinical and Pre-Clinical Pipeline and Unique Host-Mimetic, Virus Killing, Technology Platform Intending To Revolutionize Treatment of Viral Infections

July 1, 2024 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its current assets and plans towards becoming a successful pharmaceutical company intending to revolutionize the treatment of viral infections.NV-387, our lead broad-spectrum antiviral drug candidate has completed Phase I clinical trial in healthy subjects with no drop-outs and no reported adverse...

Read more

Biophytis Presented its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris

July 1, 2024 1:20 AM

Biophytis SA (Euronext Growth Paris : ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, presented the roll-out and results of its phase 2/3 COVA study in the treatment of severe forms of Covid-19 at the 6th edition of the World Congress on Infectious Diseases, held from June 24 to 26, 2024 in Paris, France.Professor Valerie Pourcher MD, PhD,...

Read more

GLG Life Tech Corporation Reports 2023 Annual & Fourth Quarter Financial Results

June 28, 2024 6:30 PM

GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and twelve months ended December 31, 2023. The complete set of financial statements and management discussion and analysis are available on SEDAR and on the Company's website at www.glglifetech.com.FINANCIAL SUMMARYThe Company...

Read more

FSD Pharma provides Corporate Update

June 28, 2024 5:00 PM

TORONTO, ON / ACCESSWIRE / June 28, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.Corporate UpdateFSD Pharma has retained the services of Totaligent, Inc. ("Totaligent") who will play a key role in assisting the Company to enhance its market...

Read more

Supreme Court Ruling: MMJ Prepares To Up End DEA's "Kangaroo Court" And Anti Marijuana Research Policy

June 28, 2024 3:45 PM

In a groundbreaking decision, the Supreme Court has ruled in Jarkesy v. SEC that defendants are entitled to a jury trial under the Seventh Amendment when facing enforcement actions from federal agencies. This decision challenges the constitutionality of using administrative law judges (ALJs) in federal agencies like the DEA, suggesting that enforcement actions must be brought in federal court where defendants can have a jury trial. This ruling...

Read more

Bristol Myers Squibb Named to Dow Jones Sustainability Index North America

June 28, 2024 3:40 PM

PRINCETON, NJ / ACCESSWIRE / June 28, 2024 / Bristol Myers Squibb CompanyRecognition underscores BMS' commitment to innovation, responsibility and growthBristol Myers Squibb (NYSE:BMY) has been named to the prestigious 2023 Dow Jones Sustainability Index (DJSI) North America, validating the company's meaningful progress, evolved strategy and aspirational goals toward its environmental, social and governance efforts.BMS has made significant...

Read more

samrecover(R) Sponsors NFL Player Derrick Gore's Youth Football Camp

June 28, 2024 1:50 PM

Inventors of the sustained acoustic medicine ultrasound treatment, popular with football players and other athletes for promoting injury healing, will provide gear for the camp supporting young athletes in Syracuse, N.Y.TRUMBULL, CT / ACCESSWIRE / June 28, 2024 / samrecover®, a medical device company and creator of the sam® wearable ultrasound unit for soft tissue healing, along with LnUP, is sponsoring a free youth football camp hosted by NFL...

Read more

Exploring the Latest in Dental Crown Technology and Procedures in Port Saint Lucie, FL

June 28, 2024 12:00 PM

Dental crowns have come a long way in recent years, and today's crowns are practically indistinguishable from natural teeth. Dental crowns may be a solution your dentist recommends if you've had damage to one or more teeth or are experiencing tooth decay. A local dentist in Port St. Lucie can help you review the procedure and explore whether it makes sense for you. Before visiting your dentist, familiarize yourself with these advancements in...

Read more

Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules

June 28, 2024 9:20 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that it has entered into securities purchase agreements with certain healthcare-focused and institutional investors to purchase (i) 5,339,806 shares of its common stock or pre-funded warrants in lieu thereof and (ii)...

Read more

NLS Pharmaceutics Announces Registered Direct Offering

June 28, 2024 9:00 AM

ZURICH, SWITZERLAND / ACCESSWIRE / June 28, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 3,277,750 of its common...

Read more

THIRA Health Welcomes Dr. Al Tsai, MD, as New Medical Director

June 28, 2024 9:00 AM

Thira Health Expands Clinical Expertise With Appointment of Dr. Al TsaiBELLEVUE, WA / ACCESSWIRE / June 28, 2024 / THIRA Health is pleased to announce the appointment of Dr. Al Tsai, MD, as the new Medical Director, effective July 2024. Dr. Tsai joins THIRA Health with a distinguished career characterized by rigorous training, diverse clinical expertise, and a deep commitment to advancing psychiatric care. THIRA Logo Dr. Tsai earned his...

Read more

KindlyMD Announces First Quarter 2024 Financial Results and Provides Shareholder Update

June 28, 2024 9:00 AM

KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced its financial results for the first quarter ended March 31, 2024 and provided an update to shareholders after closing its initial public offering on June 3, 2024."We are pleased to report...

Read more